Billion to One

Palo Alto (CA)

Billion to One aims to make prenatal testing safe and affordable for every expecting mother with novel technology that can detect even single-gene disorders such as thalassemia through a simple blood test.


News about Billion to One

Blood Test to Detect Prenatal Genetic Defects to Soon be a Reality

A recent article on BillionToOne –   A unique healthcare innovation by a young Indian scientist has the potential to radically change how prenatal genetic testing is done to identify fetal abnormalities. FIT interviews Sukrit Silas, a PhD from Stanford and the Chief Science Officer at BillionToOne, a Y Combinator Company. They’ve developed a ...

Read More

Prenatal Testing Firm BillionToOne Closes $15M Series A Financing

From Genome Web –  NEW YORK (GenomeWeb) – BillionToOne, a Bay Area startup developing a molecular counting technology for noninvasive prenatal testing, said today that is has closed an oversubscribed $15 million Series A financing round. Hummingbird Ventures and NeoTribe Ventures led the investment round, with participation from Y Combinator, Civilization Ventures, Fifty Years, 500 ...

Read More